Evidence map›Paper›PMID 30842808›Full record

ArticleWorld journal of stem cells2019

Triple-modal imaging of stem-cells labeled with multimodal nanoparticles, applied in a stroke model.

Helio Rodrigues da Silva, Javier Bustamante Mamani, Mariana Penteado Nucci, Leopoldo Penteado Nucci, Andrea Tiemi Kondo, Daianne Maciely Carvalho Fantacini, Lucas Eduardo Botelho de Souza, Virginia Picanço-Castro, Dimas Tadeu Covas, José Mauro Kutner and 3 more

Abstract read
In one paragraph

Article in World journal of stem cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Helio Rodrigues da SilvaHospital Israelita Albert Einstein, São Paulo 05651-900, Brazil.
Javier Bustamante MamaniHospital Israelita Albert Einstein, São Paulo 05651-900, Brazil.
Mariana Penteado NucciLIM44, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo 05403-010, Brazil.
Leopoldo Penteado NucciCentro Universitário do Planalto Central, Brasilia 72445-020, Brazil.
Andrea Tiemi KondoHospital Israelita Albert Einstein, São Paulo 05651-900, Brazil.
Daianne Maciely Carvalho FantaciniFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo 05403-010, Brazil.
Lucas Eduardo Botelho de SouzaFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo 05403-010, Brazil.
Virginia Picanço-CastroFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo 05403-010, Brazil.
Dimas Tadeu CovasFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo 05403-010, Brazil.
José Mauro KutnerHospital Israelita Albert Einstein, São Paulo 05651-900, Brazil.
Fernando Anselmo de OliveiraHospital Israelita Albert Einstein, São Paulo 05651-900, Brazil.
Nelson HamerschlakHospital Israelita Albert Einstein, São Paulo 05651-900, Brazil.
Lionel Fernel GamarraHospital Israelita Albert Einstein, São Paulo 05651-900, Brazil. lgamarra@einstein.br.
Hospital Israelita Albert Einstein · BRUniversidade de Ribeirão Preto · BRCentral Bank of Brazil · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMesenchymal stem cells (MSCs) have been widely tested for their therapeutic efficacy in the ischemic brain and have been shown to provide several benefits. A major obstacle to the clinical translation of these therapies has been the inability to noninvasively monitor the best route, cell doses, and collateral effects while ensuring the survival and effective biological functioning of the transplanted stem cells. Technological advances in multimodal imaging have allowed

aimTo evaluate the sensitivity of triple-modal imaging of stem cells labeled with MNPs and applied in a stroke model.

methodsAfter the isolation and immunophenotypic characterization of human bone marrow MSCs (hBM-MSCs), our team carried out lentiviral transduction of these cells for the evaluation of bioluminescent images (BLIs)

resultshBM-MSC collection and isolation after immunophenotypic characterization were demonstrated to be adequate in hBM samples. After transduction of these cells with luciferase (hBM-MSC

conclusionThis study highlighted the importance of quantifying MNPs internalized into cells and the efficacy of signal detection under the triple-image modality in a stroke model.

Indexed as

BioluminescenceHuman bone marrow mesenchymal stem cellsMagnetic resonance imageMultimodal nanoparticlesNear-infrared fluorescence imageStroke

Identifiers

PMID30842808
PMCPMC6397806
OpenAlexW2915225750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.